IMPACT Therapeutics, Inc - B - H Shares Stock: price and insider trades · Hong Kong
1 insider bought €160k of shares over the last 90 days, the latest by CAI Sui Xiong, filed 03 Sept 2026.
IMPACT Therapeutics, Inc - B - H Shares: what insiders have been doing
IMPACT Therapeutics, Inc - B - H Shares is a Health Care company. Its directors and officers file their transactions with HKEX. From 23 October 2025 to 23 October 2026, the disclosure feed for IMPACT Therapeutics, Inc - B - H Shares logged 9 filings by 4 insiders.
Not one open-market sale was filed. On the buying side, 1 insider reported 1 purchase totalling €160k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Biggest ticket of the year: €160k, bought by CAI Sui Xiong and made public on 3 September 2026 (0.019% of market cap). The buyers include 1 senior executive.
The most recent open-market purchase was published on 3 September 2026, 66 days ago. Between a trade and the moment it shows up on HKEX, the median delay is 8 days. Until a filing is published, the market cannot know about the trade.
Across the 1,315 companies tracked on its exchange, the median is 4 filings; at 9 filings, this issuer sits above that mark. The full history, which starts in 2026, counts 1 purchase against no sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- -10.2%Entry HK$2.45 · Close at T+30 HK$2.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 100,000 shares@ HK$14.61050.019% mcap100.0% of flowShareXHKGHKEX:DA20260903E00086Canonical exit: 30 Nov 2026 (T+90)
- 18,440,884 sharesShareXHKGHKEX:DA20260618E00019
- 7,261,889 sharesShareXHKGHKEX:DA20260618E00020
- 7,921,202 sharesShareXHKGHKEX:DA20260618E00021
- 18,440,884 sharesShareXHKGHKEX:DA20260618E00018
- 18,440,884 sharesShareXHKGHKEX:DA20260522E00324
- 7,921,202 sharesShareXHKGHKEX:DA20260522E00337
- 7,261,889 sharesShareXHKGHKEX:DA20260522E00336
- 18,440,884 sharesShareXHKGHKEX:DA20260522E00333
9 of 9 declarations
About IMPACT Therapeutics, Inc - B - H Shares
IMPACT Therapeutics, Inc - B - H Shares is a company focused on developing innovative cancer treatments. It specializes in the research and commercialization of targeted therapies.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
